"10.1371_journal.pone.0047905","plos one","2012-10-24T00:00:00Z","Liyong Wu; Jared Rowley; Sara Mohades; Antoine Leuzy; Marina Tedeschi Dauar; Monica Shin; Vladimir Fonov; Jianping Jia; Serge Gauthier; Pedro Rosa-Neto; the Alzheimerâ€™s Disease Neuroimaging Initiative","Translational Neuroimaging Laboratory, Douglas Hospital, McGill University, Montreal, Quebec, Canada; McGill Centre for Studies in Aging, McGill University, Montreal, Quebec, Canada; Department of Neurology, Xuan Wu Hospital, Capital Medical University, Beijing, China; McConnell Brain Imaging Centre, Montreal Neurological Institute, McGill University, Montreal, Quebec, Canada","Conceived and designed the experiments: LW PR. Performed the experiments: JR LW. Analyzed the data: JR LW PR. Contributed reagents/materials/analysis tools: SM MS VF PR JR. Wrote the paper: LW SM AL MD MS JJ SG PR.","The Alzheimers Disease Neuroimaging Initiative study received funding for data collection and sharing from commercial sources (Abbott; Amorfix Life Sciences Ltd.; AstraZeneca; Bayer HealthCare; BioClinica, Inc.; Biogen Idec Inc.; Bristol-Myers Squibb Company; Eisai Inc.; Elan Pharmaceuticals Inc.; Eli Lilly and Company; F. Hoffmann-La Roche Ltd and its affiliated company Genentech, Inc.; GE Healthcare; Innogenetics, N.V.; Janssen Alzheimer Immunotherapy Research & Development, LLC.; Johnson & Johnson Pharmaceutical Research & Development LLC.; Medpace, Inc.; Merck & Co., Inc.; Meso Scale Diagnostics, LLC.; Novartis Pharmaceuticals Corporation; Pfizer Inc.; Servier; Synarc Inc.; and Takeda Pharmaceutical Company. ). This does not alter the authors adherence to all the PLOS ONE policies on sharing data and materials.","2012","10","Liyong Wu","LW",11,TRUE,2,2,3,8,TRUE,TRUE,TRUE,1,"11",TRUE
